Resistin as an Inflammation Marker in Lupus
Author Information
Author(s): Almehed Katarina, Forsblad d'Elia Helena, Bokarewa Maria, Carlsten Hans
Primary Institution: Sahlgrenska Academy at Göteborg University
Hypothesis
The study aims to determine associations between serum levels of resistin and markers of inflammation and bone mineral density in female patients with systemic lupus erythematosus.
Conclusion
Resistin was associated with general inflammation, renal disease, treatment with glucocorticosteroids, and bone loss in patients with systemic lupus erythematosus.
Supporting Evidence
- Resistin levels were similar in patients with SLE and healthy controls.
- Markers of inflammation correlated positively with serum resistin levels.
- Resistin was significantly associated with bone mineral density and renal function.
Takeaway
This study looked at a protein called resistin in women with lupus and found it linked to inflammation and bone health.
Methodology
A cross-sectional study analyzing serum resistin levels and various inflammatory markers in female patients with systemic lupus erythematosus.
Potential Biases
Potential bias due to the reliance on self-reported data for medication and lifestyle factors.
Limitations
The study only included female patients, which may limit the generalizability of the findings.
Participant Demographics
163 female patients aged 20 to 82 years, with a majority being premenopausal.
Statistical Information
P-Value
0.001
Confidence Interval
95% CI not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website